Company Description
American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment.
It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.
It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers.
The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide.
American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
Country | United States |
Founded | 1980 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 31 |
CEO | Raymond C. Stachowiak |
Contact Details
Address: 601 Montgomery Street, Suite 1112 San Francisco, California 94111 United States | |
Phone | 415-788-5300 |
Website | ashs.com |
Stock Details
Ticker Symbol | AMS |
Exchange | NYSEAMERICAN |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000744825 |
CUSIP Number | 029595105 |
ISIN Number | US0295951059 |
Employer ID | 94-2918118 |
SIC Code | 8071 |
Key Executives
Name | Position |
---|---|
Peter Gaccione | Chief Executive Officer |
Raymond C. Stachowiak | Executive Chairman |
Craig K. Tagawa | President and Assistant Secretary |
Robert L. Hiatt | Chief Financial Officer |
Alexis N. Wallace CPA | Chief Accounting Officer and Corporate Secretary |
Ranjit Pradhan | Head of Marketing and Customer Advocacy |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 2, 2024 | 8-K | Current Report |
May 15, 2024 | 10-Q | Quarterly Report |
May 14, 2024 | 8-K | Current Report |
May 13, 2024 | 8-K | Current Report |
Apr 29, 2024 | ARS | Filing |
Apr 29, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 29, 2024 | DEF 14A | Other definitive proxy statements |
Apr 18, 2024 | 8-K | Current Report |
Apr 3, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Apr 1, 2024 | 10-K | Annual Report |